Promethazine Theoclate IP/BP represents a premium-grade active pharmaceutical ingredient manufactured to exacting Indian Pharmacopoeia and British Pharmacopoeia standards. This his...

Promethazine Theoclate IP/BP represents a premium-grade active pharmaceutical ingredient manufactured to exacting Indian Pharmacopoeia and British Pharmacopoeia standards. This histamine H1-receptor antagonist combines promethazine with 8-chlorotheophylline to create a highly effective antiemetic compound specifically designed for motion sickness and nausea control. The synthesis process ensures exceptional purity levels and batch-to-batch consistency, making it suitable for pharmaceutical companies requiring reliable API sourcing. Our manufacturing facilities maintain GMP compliance throughout production, delivering material that meets stringent quality control parameters for potency, impurities, and stability.

The pharmaceutical industry extensively utilizes Promethazine Theoclate in formulations targeting motion sickness, vertigo, and nausea across multiple therapeutic segments. Travel medicine manufacturers incorporate this API into tablets and capsules for consumers facing long-distance travel by air, sea, or road. Hospital pharmacies stock medications containing this compound for postoperative nausea management and chemotherapy-induced vomiting prevention. Veterinary pharmaceutical companies also employ this ingredient in animal health products addressing motion sickness during transport. The versatility of this API allows formulators to create immediate-release and sustained-release dosage forms catering to different patient needs and administration requirements.

Businesses choosing our Promethazine Theoclate IP/BP gain access to a consistently reliable API supply that reduces formulation challenges and production delays. The compound's established safety profile and proven efficacy minimize regulatory approval timelines for new drug applications. Our manufacturing process incorporates rigorous quality checks at multiple stages, ensuring that every batch delivers predictable performance in final formulations. The product's stability under various storage conditions extends shelf life and reduces waste throughout the supply chain. Pharmaceutical companies benefit from our technical support and documentation that facilitates seamless integration into manufacturing processes.

Key Features:
- Manufactured to IP/BP pharmacopoeia standards ensuring regulatory compliance
- High purity levels with controlled impurity profiles for formulation safety
- Excellent stability characteristics supporting extended product shelf life
- Consistent particle size distribution for optimal manufacturing processing
- Batch-to-batch consistency maintained through rigorous quality control protocols

Benefits:
- Reduced regulatory approval timelines due to established safety profile
- Predictable performance in final formulations ensuring therapeutic efficacy
- Extended shelf life and reduced waste throughout the supply chain
- Seamless integration into existing manufacturing processes
- Reliable supply chain with consistent quality and documentation support